SM 5887

SM 5887 구조식 이미지
카스 번호:
110311-30-3
상품명:
SM 5887
동의어(영문):
Calsed;SM 5887;AMR hydrochloride;Amrubicin hydrochloride;BHMLHEQFWVQAJS-IERVSNJOSA-N;(1S,3S)-3-Acetyl-3-amino-5,12-dihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl2-deoxy-β-D-erythro-pentopyranosidehydrochloride(1:1);(7S,9S)-9-Acetyl-9-amino-7-(2-deoxy-β-D-erythro-pentopyranosyloxy)-6,11-dihydroxy-5,7,8,9,10,12-hexahydro-5,12-naphthacenedione·hydrochloride
CBNumber:
CB21374151
분자식:
C25H25NO9.ClH
포뮬러 무게:
519.931
MOL 파일:
110311-30-3.mol

SM 5887 속성

녹는점
145-151°

안전

독성 LD50 i.v. in mice: 32-50 mg/kg (Morisada)

SM 5887 C화학적 특성, 용도, 생산

개요

small and small-cell lung cancers. Amrubicin, a completely synthetic anthracycline derivative, mediates its growth inhibitory action via topoisomerase II inhibition. It is activated in viva by the formation of its 13-OH metabolite, amrubicinol, via reaction with carbonyl reductase. In contrast to doxorubicin and daunorubicin whose metabolites are inactive in the blood, amrubicinol is 10-100 fold more cytotoxic than amrubicin. In phase II clinical trials, amrubicin showed antitumor activity against non-small-cell lung cancers (response rate exceeding 20%) and against untreated extensive stage small-cell-lung cancers (response rate 78.8%). Amrubicin demonstrated a smaller distribution-volume, a shorter half-life in mice and also less chronic cardiotoxicity in preclinical studies compared to doxorubicin. Amrubicin was generally well tolerated with major adverse events being anaemia, leucopenia, thrombocytopenia and neutropenia.

Originator

Sumitomo (Japan)

상표명

Calsed

SM 5887 준비 용품 및 원자재

원자재

준비 용품


SM 5887 공급 업체

글로벌( 13)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152
Mandy@hangyubiotech.com China 10991 58
MedChemexpress LLC 021-58955995
sales@medchemexpress.cn United States 4863 58
BOC Sciences 16314854226
info@bocsci.com United States 9926 65
Musechem +1-800-259-7612
info@musechem.com United States 4662 60
Shenzhen Botel Biotechnology Co. Ltd. 0755-22202135 13316968096
1979313431@qq.com China 8734 58
Beijing xinyanhui pharmaceutical research and development co., LTD 13969155946
1461866103@qq.com China 16111 58
Absin Bioscience Inc. 021-38015121 15000105423
wulan@absin.cn China 24734 58
Hubei Xinyang Medical Technology Co., Ltd 15347293736 15347293736
2853117764@qq.com China 8311 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581
sales@chemhifuture.com China 4679 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050
cb5@aikonchem.com China 10529 58

Copyright 2019 © ChemicalBook. All rights reserved